Chinese | English
Log In By IDS | Log In By KMS | Register
Search in the results
兰州大学机构库

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study 期刊论文
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 卷号: 98, 期号: 11, 页码: 1742-1750
Authors:  Deng, Lijuan;  Li, Zhiming;  Zhang, Huilai;  Huang, Haiwen;  Hu, Jianda;  Liu, Lihong;  Liu, Ting;  Jin, Jie;  Zhu, Zunmin;  Li, Wenyu...Deng, Lijuan;  Li, Zhiming;  Zhang, Huilai;  Huang, Haiwen;  Hu, Jianda;  Liu, Lihong;  Liu, Ting;  Jin, Jie;  Zhu, Zunmin;  Li, Wenyu;  Huang, Zhenqian;  Huang, Wenrong;  Zhou, Keshu;  Yang, Haiyan;  Zhang, Mingzhi;  Ding, Kaiyang;  Zhou, Hui;  Hu, Yu;  Shuang, Yuerong;  Cao, Junning;  Gao, Sujun;  Li, Dengju;  Sun, Zimin;  Zhang, Qingyuan;  Yi, Shuhua;  Ji, Chunyan;  Zhang, Liansheng;  Hou, Cheng;  Du, Yue;  Wang, Weige;  Zhao, Renbin;  Song, Yuqin;  Zhu, Jun
Favorite  |    Submit date：2023/11/28
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study 期刊论文
The Innovation, 2023, 卷号: 4, 期号: 3
Authors:  Zhong, Huijuan;  Cheng, Shu;  Zhang, Xi;  Xu, Bing;  Chen, Jiayi;  Jiang, Xufeng;  Xiong, Jie;  Hu, Yu;  Cui, Guohui;  Wei, Juying...Zhong, Huijuan;  Cheng, Shu;  Zhang, Xi;  Xu, Bing;  Chen, Jiayi;  Jiang, Xufeng;  Xiong, Jie;  Hu, Yu;  Cui, Guohui;  Wei, Juying;  Qian, Wenbin;  Huang, Xiaobing;  Hou, Ming;  Yan, Feng;  Wang, Xin;  Song, Yongping;  Hu, Jianda;  Liu, Yuanhua;  Ma, Xuejun;  Li, Fei;  Wu, Chongyang;  Chen, Junmin;  Yu, Li;  Bai, Ou;  Xu, Jingyan;  Zhu, Zunmin;  Liu, Li;  Zhou, Xin;  Huang, Li;  Tong, Yin;  Niu, Ting;  Wu, Depei;  Zhang, Hao;  Wang, Chaofu;  Ouyang, Binshen;  Yi, Hongmei;  Song, Qi;  Cai, Gang;  Li, Biao;  Liu, Jia;  Li, Zhifeng;  Xiao, Rong;  Wang, Luqun;  Jiang, Yujie;  Liu, Yanyan;  Zheng, Xiaoyun;  Xu, Pengpeng;  Huang, Hengye;  Wang, Li;  Chen, Saijuan;  Zhao, Weili
Favorite  |    Submit date：2023/05/25
Oncology  Sensitivity analysis  Adverse events  Confidence interval  Dexamethasones  Etoposide  Four cycles  Natural killer T cell  Non-inferiority  Randomisation  Response rate  T-cell lymphomas  
Comparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthere (R)) in combination with CHOP in patients with previously untreated CD20-positive diffuse large B-cell lymphoma: A randomized, single-blind, phase III clinical trial 期刊论文
HEMATOLOGICAL ONCOLOGY, 2022
Authors:  Shi, Yuankai;  Zhang, Qingyuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan;  Zou, Liqun;  Cen, Hong;  Gui, Lin;  Li, Yufu;  Feng, Jifeng...Shi, Yuankai;  Zhang, Qingyuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan;  Zou, Liqun;  Cen, Hong;  Gui, Lin;  Li, Yufu;  Feng, Jifeng;  Wang, Zhao;  Zhang, Mingzhi;  Jin, Chuan;  Zhang, Weihua;  Hu, Jianda;  Zheng, Chengyun;  Zheng, Zhendong;  Zhang, Liling;  Chen, Shaoshui;  Huang, Yunhong;  Tang, Yun;  Gao, Yajie;  Hao, Miaowang;  Li, Xiaoling;  Chang, Chunkang;  Yang, Haiyan;  Wu, Hui;  Shen, Lida;  Ke, Xiaoyan;  Zhang, Liangming;  Xi, Yaming;  Yang, Linhua;  Xie, Liangzhi;  Gai, Wenlin;  Ji, Yanan
Favorite  |    Submit date：2022/11/09
CHOP  DLBCL  Mabthera (R)  ripertamab  rituximab  
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 卷号: 14, 期号: 1
Authors:  Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda...Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda;  Hou, Ming;  Yao, Yazhou;  Liu, Li;  Wang, Yi;  Wu, Depei;  Zhang, Liansheng;  Zheng, Changcheng;  Shen, Xuliang;  Hu, Qi;  Liu, Jing;  Jin, Jie;  Luo, Jianmin;  Zeng, Yun;  Gao, Sujun;  Zhang, Xiaohui;  Zhou, Xin;  Shi, Qingzhi;  Xia, Ruixiang;  Xie, Xiaobao;  Jiang, Zhongxing;  Gao, Li;  Bai, Yuansong;  Li, Yan;  Xiong, Junye;  Li, Runzi;  Zou, Jianjun;  Niu, Ting;  Yang, Renchi;  Hu, Yu
Favorite  |    Submit date：2021/04/16
Immune thrombocytopenia  Hetrombopag  Thrombopoietin receptor agonists  Platelet response  
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study 期刊论文
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 卷号: 20, 期号: 3, 页码: 716-728
Authors:  Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda...Mei, Heng;  Liu, Xiaofan;  Li, Yan;  Zhou, Hu;  Feng, Ying;  Gao, Guangxun;  Cheng, Peng;  Huang, Ruibin;  Yang, Linhua;  Hu, Jianda;  Hou, Ming;  Yao, Yazhou;  Liu, Li;  Wang, Yi;  Wu, Depei;  Zhang, Liansheng;  Zheng, Changcheng;  Shen, Xuliang;  Hu, Qi;  Liu, Jing;  Jin, Jie;  Luo, Jianmin;  Zeng, Yun;  Gao, Sujun;  Zhang, Xiaohui;  Zhou, Xin;  Shi, Qingzhi;  Xia, Ruixiang;  Xie, Xiaobao;  Jiang, Zhongxing;  Gao, Li;  Bai, Yuansong;  Xiong, Junye;  Li, Runzi;  Zou, Jianjun;  Niu, Ting;  Yang, Renchi;  Hu, Yu
Favorite  |    Submit date：2022/04/20
extension period  hetrombopag  immune thrombocytopenia  platelet response  thrombopoietin receptor agonist  withdrawal